isoniazid has been researched along with mannans in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Doxsee, D; Stokes, RW | 1 |
| Aminabhavi, TM; Kajjari, PB; Manjeshwar, LS | 1 |
| Garg, T; Goyal, AK; Gupta, P; Gupta, UD; Kaur, R; Malik, B; Rath, G | 1 |
| Garg, T; Goyal, AK; Gupta, P; Gupta, UD; Rath, G | 1 |
| Alves, AD; Buttini, F; Cavaco, JS; Grenha, A; Guerreiro, F; Pontes, JF; Rodrigues, S; Rosa da Costa, AM | 1 |
| Chatterji, D; Jayaraman, N; Maiti, K; Syal, K | 1 |
| Almeida, AJ; Alves, AD; Gaspar, MM; Grenha, A; Guerreiro, F; Pinho, J; Simões, S | 1 |
7 other study(ies) available for isoniazid and mannans
| Article | Year |
|---|---|
The receptor-mediated uptake, survival, replication, and drug sensitivity of Mycobacterium tuberculosis within the macrophage-like cell line THP-1: a comparison with human monocyte-derived macrophages.
Topics: Adult; Antibodies; Antitubercular Agents; Bacterial Adhesion; Cell Line; Glucans; Humans; Isoniazid; Macrophage-1 Antigen; Macrophages; Mannans; Microbial Sensitivity Tests; Monocytes; Mycobacterium tuberculosis; Polysaccharides; Receptors, Complement 3b; Receptors, Fc; Receptors, Mitogen; Zymosan | 1999 |
Novel pH- and temperature-responsive blend hydrogel microspheres of sodium alginate and PNIPAAm-g-GG for controlled release of isoniazid.
Topics: Acrylamides; Acrylic Resins; Alginates; Antitubercular Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Delayed-Action Preparations; Emulsions; Galactans; Glucuronic Acid; Glutaral; Half-Life; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogen-Ion Concentration; Isoniazid; Kinetics; Mannans; Microscopy, Electron, Scanning; Microspheres; Plant Gums; Polymers; Spectroscopy, Fourier Transform Infrared; Temperature; X-Ray Diffraction | 2012 |
Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs.
Topics: Animals; Antitubercular Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Female; Galactans; Isoniazid; Lung; Male; Mannans; Mycobacterium tuberculosis; Nanoparticles; Plant Gums; Porosity; Rats; Rats, Wistar; Rifampin; Tuberculosis | 2016 |
Chemotherapeutic Evaluation of Guar Gum Coated Chitosan Nanoparticle Against Experimental Tuberculosis.
Topics: Animals; Antitubercular Agents; Chitosan; Coated Materials, Biocompatible; Delayed-Action Preparations; Diffusion; Female; Galactans; Isoniazid; Mannans; Mice; Mice, Inbred BALB C; Nanocapsules; Plant Gums; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
Dual antibiotherapy of tuberculosis mediated by inhalable locust bean gum microparticles.
Topics: Administration, Inhalation; Animals; Antitubercular Agents; Cell Line; Drug Carriers; Galactans; Humans; Isoniazid; Mannans; Plant Gums; Rats; Rifabutin; Tuberculosis | 2017 |
Synthetic Arabinomannan Heptasaccharide Glycolipids Inhibit Biofilm Growth and Augment Isoniazid Effects in Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Biofilms; Dose-Response Relationship, Drug; Glycolipids; Isoniazid; Mannans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium smegmatis; Oligosaccharides; Structure-Activity Relationship | 2017 |
Inhalable locust bean gum microparticles co-associating isoniazid and rifabutin: Therapeutic assessment in a murine model of tuberculosis infection.
Topics: Administration, Oral; Animals; Antitubercular Agents; Disease Models, Animal; Drug Combinations; Galactans; Isoniazid; Macrophages; Mannans; Mice; Mice, Inbred BALB C; Microspheres; Mycobacterium tuberculosis; Plant Gums; Rifabutin; Tuberculosis | 2020 |